Axcelead Looks to Unearth New Drugs from Takeda’s Legacy Assets, 5-Plus Collaborations Ongoing

December 23, 2020
Historically, Takeda Pharmaceutical has been the leader in Japan’s small molecule drug discovery research. Its drug discovery function has now been hived off as an independent company called Axcelead Drug Discovery Partners, and the spinoff is looking to tap into...read more